November 15, 2018
Camel-IDS completes EUR 37m Series A financing to develop cancer-targeted radiopharmaceuticals
Media
November 13, 2018
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
November 08, 2018
InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones
November 08, 2018
Interim report July-September 2018
November 07, 2018
Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of sickle cell disease
November 07, 2018
MIPS INTERIM REPORT JANUARY – SEPTEMBER 2018
November 07, 2018
BONESUPPORT HOLDING AB (publ) – Interim Report
November 06, 2018
Nordic Nanovector ASA: Results for the Third Quarter 2018
November 05, 2018
Additional steps towards the commercialization of Ygalo®
November 05, 2018
EXTRAORDINARY GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)
